login
login

Europe Daily Bulletin No. 12514

26 June 2020
EU RESPONSE TO COVID-19 / Health
European Medicines Agency recommends conditional marketing authorisation for remdesivir
25/06/2020 (Agence Europe)

25/06/2020 (Agence Europe)The European Medicines Agency (EMA) recommended on Thursday 25 June that a conditional marketing authorisation be granted to Veklury (i.e. remdesivir) for the treatment of Covid-19 in adults and adolescents from 12 years of age with severe pneumonia. Remdesivir is the first drug recommended for authorisation in the EU to combat the virus, the agency explains. The study, based on a sample of more than 1,000 patients, would have shown, according to the Agency,...

Contents

ECONOMY - FINANCE
EU RESPONSE TO COVID-19
SECTORAL POLICIES
SECURITY - DEFENCE
EXTERNAL ACTION
COURT OF JUSTICE OF THE EU
NEWS BRIEFS
CORRIGENDUM